9 Meters Biopharma, Inc.
NMTRDelisted Sep 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001551986
9 Meters Biopharma, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Apr 21, 2023; 34 institutions reported holding it in 13F filings for Q2 2023, worth $2.08M in total; no superinvestor held it.
13F holders, Q2 2022
Institutional positions in 9 Meters Biopharma, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 88
- −12 vs. Q1 2022
- Shares held
- 58.4M
- −17.2M (−22.7%) vs. Q1 2022
- Total value
- $15.2M
- −$30.0M (−66.3%) vs. Q1 2022
- New holders
- 17
- 22 more added
- Sold out
- 29
- 18 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NMTR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 1 | $0 |
| Q1 2025 | 1 | $0 |
| Q4 2024 | 1 | $0 |
| Q3 2024 | 1 | $0 |
| Q2 2024 | 1 | $6.43K |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 1 | $0 |
| Q3 2023 | 6 | $22.7K |
| Q2 2023 | 34 | $2.08M |
| Q1 2023 | 39 | $4.45M |
| Q4 2022 | 42 | $3.02M |
| Q3 2022 | 74 | $10.4M |
| Q2 2022 | 88 | $15.2M |
| Q1 2022 | 101 | $45.2M |
| Q4 2021 | 104 | $76.8M |
| Q3 2021 | 105 | $94.2M |
| Q2 2021 | 99 | $81.8M |
| Q1 2021 | 90 | $88.8M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding 9 Meters Biopharma, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| ProShare Advisors LLC | 0 | $0 | 0.00% | −42,452−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −40,108−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −37,700−100.0% | Sold out |
| Prentice Wealth Management LLC | 0 | $0 | 0.00% | −39,525−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −36,861−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −23,661−100.0% | Sold out |
| Sterling Investment Counsel, LLC | 0 | $0 | 0.00% | −17,533−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −16,663−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −15,225−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −15,319−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −15,303−100.0% | Sold out |
| Mackenzie Financial Corp | 0 | $0 | 0.00% | −12,358−100.0% | Sold out |
| Xponance, Inc. | 0 | $0 | 0.00% | −10,743−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −122−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −600−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −190−100.0% | Sold out |
| Covestor Ltd | 0 | $0 | 0.00% | −125−100.0% | Sold out |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |